HighMark Wealth Management’s MEI Pharma MEIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $708 | Hold |
287
| – | – | ﹤0.01% | 543 |
|
|
2025
Q1 | $628 | Sell |
287
-5
| -2% | -$11 | ﹤0.01% | 510 |
|
|
2024
Q4 | $718 | Hold |
292
| – | – | ﹤0.01% | 511 |
|
|
2024
Q3 | $831 | Hold |
292
| – | – | ﹤0.01% | 525 |
|
|
2024
Q2 | $849 | Hold |
292
| – | – | ﹤0.01% | 515 |
|
|
2024
Q1 | $1.17K | Hold |
292
| – | – | ﹤0.01% | 499 |
|
|
2023
Q4 | $1.69K | Sell |
292
-238
| -45% | -$1.38K | ﹤0.01% | 480 |
|
|
2023
Q3 | $3.72K | Hold |
530
| – | – | ﹤0.01% | 388 |
|
|
2023
Q2 | $3.49K | Hold |
530
| – | – | ﹤0.01% | 400 |
|
|
2023
Q1 | $2.43K | Hold |
530
| – | – | ﹤0.01% | 483 |
|
|
2022
Q4 | $2.58K | Sell |
530
-500
| -49% | -$2.44K | ﹤0.01% | 408 |
|
|
2022
Q3 | $8K | Sell |
1,030
-109
| -10% | -$847 | 0.01% | 273 |
|
|
2022
Q2 | $14K | Sell |
1,139
-41
| -3% | -$504 | 0.01% | 206 |
|
|
2022
Q1 | $14K | Hold |
1,180
| – | – | 0.01% | 215 |
|
|
2021
Q4 | $63K | Sell |
1,180
-146
| -11% | -$7.8K | 0.04% | 100 |
|
|
2021
Q3 | $73K | Buy |
1,326
+17
| +1% | +$936 | 0.05% | 96 |
|
|
2021
Q2 | $59K | Buy |
1,309
+1,090
| +498% | +$49.1K | 0.04% | 104 |
|
|
2021
Q1 | $15K | Sell |
219
-24
| -10% | -$1.64K | 0.01% | 192 |
|
|
2020
Q4 | $13K | Sell |
243
-587
| -71% | -$31.4K | 0.01% | 193 |
|
|
2020
Q3 | $52K | Buy |
+830
| New | +$52K | 0.05% | 102 |
|